SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 277 filers reported holding SAGE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,598,000 | +29.3% | 16,334 | -22.1% | 0.58% | +19.1% |
| Q4 2018 | $2,010,000 | -23.1% | 20,979 | +13.4% | 0.49% | +0.2% |
| Q3 2018 | $2,614,000 | +5.5% | 18,507 | +17.0% | 0.49% | +1.5% |
| Q2 2018 | $2,477,000 | -52.4% | 15,823 | -51.0% | 0.48% | -50.5% |
| Q1 2018 | $5,199,000 | +176.8% | 32,278 | +7.1% | 0.97% | +84.9% |
| Q3 2017 | $1,878,000 | -32.5% | 30,144 | -13.7% | 0.52% | -36.4% |
| Q2 2017 | $2,782,000 | +1.3% | 34,936 | -9.6% | 0.82% | +19.7% |
| Q1 2017 | $2,747,000 | – | 38,651 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |